Cargando…

Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation

BACKGROUND: Atrial fibrosis serves as a disease initiating mechanism in the development of atrial fibrillation. Angiotensin II (Ang-II), a key mediator for atrial fibrosis, aberrantly activates atrial fibroblasts (AFs) into myofibroblasts, resulting in subsequent excessive synthesis and deposition o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Wei, Song, Shuai, Fang, Guojian, Li, Yingze, Wang, Yuepeng, Wang, Qun-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259948/ https://www.ncbi.nlm.nih.gov/pubmed/34239314 http://dx.doi.org/10.2147/JIR.S306073

Ejemplares similares

ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway
por: Zhu, Xi, et al.
Publicado: (2021)

Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
por: Yuan, Jiali, et al.
Publicado: (2022)

Inhibition of UCHL1 by LDN-57444 attenuates Ang II–Induced atrial fibrillation in mice
por: Bi, Hai-Lian, et al.
Publicado: (2019)

Cadherin-11-Interleukin-6 Signaling between Cardiac Fibroblast and Cardiomyocyte Promotes Ventricular Remodeling in a Mouse Pressure Overload-Induced Heart Failure Model
por: Fang, Guojian, et al.
Publicado: (2023)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

USP38 exacerbates atrial inflammation, fibrosis, and susceptibility to atrial fibrillation after myocardial infarction in mice
por: Gong, Yang, et al.
Publicado: (2023)

Blockade of SK4 channels suppresses atrial fibrillation by attenuating atrial fibrosis in canines with prolonged atrial pacing
por: Wang, Youcheng, et al.
Publicado: (2022)

Isoproterenol Increases Left Atrial Fibrosis and Susceptibility to Atrial Fibrillation by Inducing Atrial Ischemic Infarction in Rats
por: Ma, Shiyu, et al.
Publicado: (2020)

Atrial fibrosis progression in patients with Atrial Fibrillation
por: White, Robert B, et al.
Publicado: (2016)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Atrial fibrosis underlying atrial fibrillation (Review)
por: Li, Chang Yi, et al.
Publicado: (2021)

Ezh2 Inhibits Replicative Senescence of Atrial Fibroblasts Through Promotion of H3K27me3 in the Promoter Regions of CDKN2a and Timp4 Genes
por: Li, Yingze, et al.
Publicado: (2022)

Tongguan capsule‐derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts
por: Ma, Shiyu, et al.
Publicado: (2018)

Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
por: Hao, Hongting, et al.
Publicado: (2022)

Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients
por: Yang, Liu, et al.
Publicado: (2022)

Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice
por: Hada, Yoshiko, et al.
Publicado: (2022)

Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation
por: Xie, Jun, et al.
Publicado: (2017)

Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?
por: Platonov, Pyotr G
Publicado: (2017)

Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?
por: Platonov, Pyotr G
Publicado: (2017)

Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
por: Shang, Luxiang, et al.
Publicado: (2020)

Atrial fibrillation
por: Munger, Thomas M., et al.
Publicado: (2014)

Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation
por: Saengklub, Nakkawee, et al.
Publicado: (2017)

Blockade of Exosome Release Suppresses Atrial Fibrillation by Alleviating Atrial Fibrosis in Canines With Prolonged Atrial Pacing
por: Yao, Yajun, et al.
Publicado: (2021)

Annotation of susceptibility SNPs associated with atrial fibrillation
por: Xu, Chengqi, et al.
Publicado: (2020)

Atrial Fibrosis by cardiac MRI is a correlate for atrial stiffness in patients with atrial fibrillation
por: Lamy, Jérôme, et al.
Publicado: (2023)

Research Progress of Myocardial Fibrosis and Atrial Fibrillation
por: Li, Guangling, et al.
Publicado: (2022)

Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
por: Ma, Jin, et al.
Publicado: (2021)

Is left atrial fibrosis an independent determinant of atrial fibrillation in mitral stenosis?
por: Pawar, Prashant, et al.
Publicado: (2021)

Right atrial function and fibrosis in relation to successful atrial fibrillation ablation
por: Hopman, Luuk H G A, et al.
Publicado: (2022)

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Atrial fibrosis in atrial fibrillation pre-ablation assessed by CMR: impact in atrial size and function?
por: Almeida, Ana G, et al.
Publicado: (2011)

The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis
por: Wang, Jiangrong, et al.
Publicado: (2019)

Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
por: Ma, Jin, et al.
Publicado: (2018)

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation
por: Hu, Juan, et al.
Publicado: (2021)

Aging and atrial fibrillation: a matter of fibrosis
por: Ravassa, Susana, et al.
Publicado: (2019)

Quantification of left atrial appendage fibrosis by cardiac magnetic resonance: an accurate surrogate for left atrial fibrosis in atrial fibrillation patients?
por: Hopman, Luuk H G A, et al.
Publicado: (2023)

Regional left atrial wall fibrosis and recurrence after atrial fibrillation ablation
por: Bieging, Erik T, et al.
Publicado: (2016)

Extensive atrial fibrosis in a patient with systemic lupus erythematosus and atrial fibrillation
por: dal Piaz, Elena Costanza, et al.
Publicado: (2015)

Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation
por: Rossi, Valentina A., et al.
Publicado: (2022)

Atrial contractile function and fibrosis in patients with paroxysmal atrial fibrillation in sinus rhythm
por: Yaroslav, Ashikhmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rivt398mhn6gge1jch3ceth40a